FrostPharma appoints Pia Renaudin as CEO and strengthens leadership team

FrostPharma announces that Pia Renaudin will become CEO on 1 January 2027. The leadership team is also strengthened by Philip Slätis as Chief Business Development Officer and Johan Lavén as Chief Commercial Officer. 

Pia Renaudin
 

The appointments will support continued growth in specialty pharma, strategic partnerships and international expansion.

“Pia, Philip and Johan strengthen and complement our leadership team. Together, they bring the experience, capabilities and leadership needed to take FrostPharma forward on our rapid growth journey, alongside all our employees.”
Rolf Clason, Chairman of the Board

Pia Renaudin brings more than 25 years of international life science experience, including senior roles at SciBase, Gilead, Nutricia and AstraZeneca.

Founders Clas Lindbergson and Fredrik Andersch will continue to support the company’s long-term development and new business opportunities.

About FrostPharma

FrostPharma is a fast-growing pharmaceutical company with Nordic roots and European reach. The company identifies, develops and commercializes value-adding medicines for patients and healthcare providers.

Contact: Fredrik Andersch, CEO
+46 737 74 40 67

fredrik.andersch@frostpharma.com

Read the full press release here:
FrostPharma appoints Pia Renaudin as CEO and strengthens leadership team | FrostPharma AB

image 4

Kontakta oss